Back to today’s briefing

Story perspectives

BriaCell's Immunotherapy Achieves 100% Tumor Resolution in 78-Year-Old

7/10/2025

32 5

Summary

Story summary

BriaCell Therapeutics celebrates a remarkable breakthrough as a 78-year-old woman with hormone receptor-positive metastatic breast cancer experiences complete lung metastasis resolution after just four doses of Bria-OTS. This stunning 100% tumor resolution, confirmed six months later, paves the way for BriaCell to delve deeper into the potential of this immunotherapy across diverse patient groups.

1 of 1

Story summary

BriaCell Therapeutics celebrates a remarkable breakthrough as a 78-year-old woman with hormone receptor-positive metastatic breast cancer experiences complete lung metastasis resolution after just four doses of Bria-OTS. This stunning 100% tumor resolution, confirmed six months later, paves the way for BriaCell to delve deeper into the potential of this immunotherapy across diverse patient groups.